(5)

Cancer Benefits and Early Detection

06/22/21 - HR Works Podcast by HR Daily Advisor

AccessHope's CEO Mark Stadler was featured on HR Daily Advisor’s HR Works podcast, where he discusses the importance of early cancer detection. During the episode, Mark dives into opportunities for employers to provide cancer-specific benefits that help enhance healthcare, patient experiences, and the value of cancer care for their employees nationwide.

Prioritizing health and well-being will serve as a competitive ...

06/10/21 - Personalization Outbreak Podcast

AccessHope’s Chair of the Board Dr. Harlan Levine recently appeared on the Personalization Outbreak podcast to share information on AccessHope’s cancer support services. During the episode, Dr. Levine talks with its host, Glenn Llopis, about how AccessHope is working to extend access for employer plan members and their local oncologists to leading cancer expertise, closing the cancer knowledge gap while leveling cancer health disparities across the country.

Democratizing access to cancer care with AccessHope

06/03/21 - Willis Towers Watson's Cure for the Common Co. Podcast

AccessHope's Chair of the Board Dr. Harlan Levine recently appeared as a guest on Willis Towers Watson’s Cure for the Common Co. podcast series. In this series that features industry leaders who are changing the way healthcare and employee benefits are delivered, Dr. Levine shares with Willis Towers Watson's Senior Director of Health and Benefits Steve Blumenfield and North America and Benefits Strategic Growth Leader Ron Fontanetta how AccessHope's remote model brings preeminent cancer expertise and outcomes to our members while addressing cancer health disparities.

Telehealth best practices: How to best care for your patients when ...

05/20/21 - Authority Magazine

AccessHope’s CMO Dr. Todd Sachs recently spoke with Authority Magazine about his background in healthcare and lessons he has learned throughout his career. In the interview, he articulates the benefits of in-person visits while discussing the challenges of virtual visits for patients, and then based on his experience, shares ways physicians can make the most of remote healthcare, especially for those living with cancer.

Robert Stone: City of Hope aims to transform cancer care nationally ...

04/02/21 - The Cancer Letter

AccessHope offers a new model that remotely connects more people with cancer through their employer health benefits to world-class cancer support from the leading institutions City of Hope and Northwestern Medicine. By engaging these employees’ local healthcare providers into collaborative relationships, AccessHope is extending the reach of leading cancer expertise to elevate local cancer care, creating a system that increases patient access to potentially lifesaving support.

Democratizing Cutting Edge Oncology Health Care by Broadening Access ...

03/05/21 - Pharmacy Times

City of Hope’s Dr. Harlan Levine spoke at the Association of Community Cancer Centers’ 47th Annual Meeting & Cancer Business Summit to share how AccessHope’s unique business model helps to unlock access to leading-edge cancer expertise and bridge the cancer knowledge gap.

Why Not Adore ADAURA?—The Trial We Need vs the Trial We Got

02/04/21 - JAMA Oncology

AccessHope’s Executive Medical Director, Jack West, MD, shares his perspective on lung cancer treatment advancements and the recent results of the ADAURA trial in a Viewpoint for JAMA Oncology.

Supporting Your Employees Facing Cancer

02/03/21 - WorldatWork

AccessHope CEO Mark Stadler shares how employer demand is accelerating the need for innovative cancer support services, driven by the goals to spend healthcare dollars wisely and ensure the best possible outcomes and quality of life for employees navigating a cancer journey.

Ruxolitinib for the Treatment of Steroid-Refractory Chronic ...

01/27/21 - JAMA Network Open

AccessHope’s Vice President and Executive Clinical Director Joseph Alvarnas, MD, published a study in JAMA Network Open highlighting the use of a new treatment for the potentially life-ending chronic graft-vs-host disease (cGVHD) resulting from allogeneic hematopoietic stem cell transplantation (HSCT).

Reimagining Cancer Care Delivery—and Serving Employers—Through ...

12/18/20 - AJMC

AccessHope Board Chair Dr. Harlan Levine spoke with AJMC’s Evidence-Based Oncology™ on the evolution of employers’ interest in cancer care, and the role they are playing to connect employees with leading-edge research.

Contact us to get started

Hope begins here.